Search Within

Mrinal M Gounder

  1. "Surgery"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (24)
  3. Book Section (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (65)
  2. Sarcoma Service (65)
  3. Solid Tumor Oncology Division (65)
  4. Surgery (65)
  5. GSK Faculty (55)
  6. Tow Center for Developmental Oncology (TCDO) (55)

More Groups

People
  1. Mary Keohan (47)
  2. William Tap (47)
  3. Sandra D'Angelo (46)
  4. Mark Dickson (43)
  5. Samuel Singer (42)
  6. Ping Chi (40)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (16)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Clinical Cancer Research (10)
  3. Annals of Oncology (3)
  4. JAMA Oncology (3)
  5. Nature Communications (3)
  6. The Oncologist (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (11)
  3. Nature Publishing Group (6)
  4. Oxford University Press (6)
  5. Springer (4)
  6. American Medical Association (3)

More Publishers

Results (65)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade
    Journal Article

    Babatunde, O. O.; Membribes, S. C.; Anthonescu, C.; Bradic, M.; O'Malley, B.; Linkov, I.; Bartlett, E.; Momtaz, P.; Alektiar, K.; Gounder, M. M.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Current management of desmoid tumors: A review
    Review

    Kasper, B.; Baldini, E. H.; Bonvalot, S.; Callegaro, D.; Cardona, K.; Colombo, C.; Corradini, N.; Crago, A. M.; Dei Tos, A. P.; Dileo, P.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • PDGFRb signaling cooperates with b-catenin to modulate c-Abl and biologic behavior of desmoid-type fibromatosis
    Journal Article

    Hu, J.; Hameed, M. R.; Agaram, N. P.; Whiting, K. A.; Qin, L. X.; Villano, A. M.; O’Connor, R. B.; Rozenberg, J. M.; Cohen, S.; Prendergast, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save